RXST vs. NTNX

Last updated Apr 1, 2026

Compare and contrast key facts about RxSight, Inc. (RXST) and Nutanix, Inc. (NTNX).

Performance

RXST vs. NTNX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RxSight, Inc. (RXST) and Nutanix, Inc. (NTNX). The values are adjusted to include any dividend payments, if applicable.

RXST vs. NTNX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RXST RxSight, Inc.	-40.88%	-69.69%	-14.73%	218.23%	12.62%	-29.69%
NTNX Nutanix, Inc.	-26.47%	-15.51%	28.29%	83.07%	-18.24%	-11.55%

Fundamentals

Market Cap RXST : $253.64M NTNX : $11.18B
EPS RXST : -$0.95 NTNX : $0.90
PS Ratio RXST : 1.88 NTNX : 4.19
Total Revenue (TTM) RXST : $134.48M NTNX : $2.69B
Gross Profit (TTM) RXST : $103.01M NTNX : $2.34B
EBITDA (TTM) RXST : -$38.63M NTNX : $300.04M

Returns By Period

In the year-to-date period, RXST achieves a -40.88% return, which is significantly lower than NTNX's -26.47% return.

RXST

• 1D: 1.15%
• 1M: -17.65%
• YTD: -40.88%
• 6M: -31.48%
• 1Y: -75.60%
• 3Y*: -28.25%
• 5Y*: —
• 10Y*: —

NTNX

• 1D: 0.21%
• 1M: -0.71%
• YTD: -26.47%
• 6M: -48.90%
• 1Y: -45.55%
• 3Y*: 13.51%
• 5Y*: 6.91%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RXST vs. NTNX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXST

RXST Risk / Return Rank: 7
RXST Sharpe Ratio Rank: 6
RXST Sortino Ratio Rank: 6
RXST Omega Ratio Rank: 4
RXST Calmar Ratio Rank: 1
RXST Martin Ratio Rank: 17

NTNX

NTNX Risk / Return Rank: 7
NTNX Sharpe Ratio Rank: 5
NTNX Sortino Ratio Rank: 7
NTNX Omega Ratio Rank: 7
NTNX Calmar Ratio Rank: 11
NTNX Martin Ratio Rank: 8

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RXST vs. NTNX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Nutanix, Inc. (NTNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RXST	NTNX	Difference
Sharpe ratio Return per unit of total volatility	-0.91	-1.00	+0.09
Sortino ratio Return per unit of downside risk	-1.47	-1.39	-0.07
Omega ratio Gain probability vs. loss probability	0.78	0.82	-0.03
Calmar ratio Return relative to maximum drawdown	-1.00	-0.84	-0.17
Martin ratio Return relative to average drawdown	-1.26	-1.58	+0.31
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RXST vs. NTNX - Sharpe Ratio Comparison

The current RXST Sharpe Ratio is -0.91, which is comparable to the NTNX Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of RXST and NTNX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RXST	NTNX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.91	-1.00	+0.09
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.27	0.01	-0.27

Correlation

The correlation between RXST and NTNX is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RXST vs. NTNX - Dividend Comparison

Neither RXST nor NTNX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

RXST vs. NTNX - Drawdown Comparison

The maximum RXST drawdown since its inception was -90.53%, which is greater than NTNX's maximum drawdown of -80.40%. Use the drawdown chart below to compare losses from any high point for RXST and NTNX.

Drawdown Indicators

	RXST	NTNX	Difference
Max Drawdown Largest peak-to-trough decline	-90.53%	-80.40%	-10.13%
Max Drawdown (1Y) Largest decline over 1 year	-76.68%	-55.63%	-21.05%
Max Drawdown (5Y) Largest decline over 5 years	—	-68.71%	—
Current Drawdown Current decline from peak	-90.42%	-54.24%	-36.18%
Average Drawdown Average peak-to-trough decline	-34.61%	-40.46%	+5.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.76%	29.48%	+31.28%

Volatility

RXST vs. NTNX - Volatility Comparison

RxSight, Inc. (RXST) has a higher volatility of 14.41% compared to Nutanix, Inc. (NTNX) at 9.66%. This indicates that RXST's price experiences larger fluctuations and is considered to be riskier than NTNX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RXST	NTNX	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.41%	9.66%	+4.75%
Volatility (6M) Calculated over the trailing 6-month period	44.06%	34.51%	+9.55%
Volatility (1Y) Calculated over the trailing 1-year period	83.74%	45.71%	+38.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.18%	48.94%	+20.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.18%	57.12%	+12.06%

Financials

RXST vs. NTNX - Profitability Comparison

The chart below illustrates the profitability comparison between RxSight, Inc. and Nutanix, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RXST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported a gross profit of 25.26M and revenue of 32.61M. Therefore, the gross margin over that period was 77.5%.

NTNX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported a gross profit of 631.55M and revenue of 722.83M. Therefore, the gross margin over that period was 87.4%.

RXST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported an operating income of -11.34M and revenue of 32.61M, resulting in an operating margin of -34.8%.

NTNX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported an operating income of 84.33M and revenue of 722.83M, resulting in an operating margin of 11.7%.

RXST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, RxSight, Inc. reported a net income of -9.15M and revenue of 32.61M, resulting in a net margin of -28.1%.

NTNX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Nutanix, Inc. reported a net income of 103.02M and revenue of 722.83M, resulting in a net margin of 14.3%.